PDF(Pubmed)
Abstract：
Colorectal cancer is the third most common cancer in the world. Surgery is mandatory to treat patients with colorectal cancer. Can colorectal cancer be treated in laparoscopy? Scientific literature has validated the oncological quality of laparoscopic approach for the treatment of patients with colorectal cancer. Randomized non-inferiority trials with good remote control have answered positively to this long-debated question. Early as 1994, first publications demonstrated technical feasibility and compliance with oncological imperatives and, as far as short-term outcomes are concerned, there is no difference in terms of mortality and post-operative morbidity between open and minimally invasive surgical approaches, but only longer operating times at the beginning of the experience. Subsequently, from 2007 onwards, long-term results were published that demonstrated the absence of a significant difference regarding overall survival, disease-free survival, quality of life, local and distant recurrence rates between open and minimally invasive surgery. In this editorial, we aim to summarize the clinical and technical aspects which, even today, make the use of open surgery relevant and necessary in the treatment of patients with colorectal cancer.
摘要：
结直肠癌是世界上第三常见的癌症。手术是治疗结直肠癌患者的强制性要求。结直肠癌可以在腹腔镜下治疗吗？科学文献已经验证了腹腔镜方法治疗结直肠癌患者的肿瘤质量。具有良好远程控制的随机非劣效性试验对这个长期争论的问题做出了积极的回答。早在1994年，第一批出版物就证明了技术可行性和符合肿瘤学要求，就短期结果而言，开放和微创手术方法在死亡率和术后发病率方面没有差异，但在体验开始时只有更长的操作时间。随后，从2007年起,发表的长期结果证明了总生存率没有显着差异，无病生存,生活质量,开放手术和微创手术之间的局部和远处复发率。在这篇社论中，我们的目的是总结临床和技术方面，即使在今天,使开腹手术在结直肠癌患者的治疗中具有相关性和必要性。
